Profiles of Urinary Tract Infections in General Practice
PODIUM
1 other identifier
observational
500
1 country
1
Brief Summary
Urinary tract infections (UTIs) are one of the most common bacterial infections managed in general practice: they are the 2nd site of community-acquired bacterial infection after respiratory infections (4-6 million consultations per year in France). UTIs represent 15% of total antibiotic prescriptions in France. Antibiotics recommended for UTIs, except for cystitis, are considered as "critical" (highly generating bacterial resistances). UTIs are a potential source of antibiotic resistance: often inappropriate antibiotic prescriptions, evolution of the resistance profiles of the bacteria involved, emergence of multi-resistant strains. The first hypothesis is that there are other profiles of clinical UTI situations in general practice than typical cystitis or pyelonephritis, including intermediate forms. The second hypothesis is that these intermediate forms of UTI are subject to longer durations of antibiotherapy, and that probable explanatory factors need to be identified.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2023
CompletedFirst Posted
Study publicly available on registry
May 6, 2023
CompletedStudy Start
First participant enrolled
December 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedJuly 3, 2024
July 1, 2024
1.1 years
April 7, 2023
July 2, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The primary outcome will be the number of homogeneous profiles of patients with UTI in general practice and their characteristics using clinico-bacteriological indicators.
The primary outcome will be the rate and the clinical-bacteriological characteristics of the identified profiles of patients with UTI in general practice
At Day 14 after the end of the Antiobiotic treatment
Secondary Outcomes (4)
For general practioners' practices:
At Day 0, at Day 14 after the end of the treatment and between Day 0 and Day14 after the end of the treatment
For short-term evolutionary trajectories:
At Day 0, at Day 14 after the end of the treatment and between Day 0 and Day 14 after the end of the treatment
For short-term evolutionary trajectories:
At Day 14 after the end of the treatment
For the factors associated with the prescription of antibiotics:
At Day 14 after the end of the treatment
Eligibility Criteria
Adult patients consulting in general practice for suspected urinary tract infection
You may qualify if:
- Patient ≥18 years old
- Patient presenting one or more of the following clinical signs suggestive of urinary tract infection in general practice consultation:
- fever (temperature \> 38°C)
- chills, sweats
- burning urination
- urinary urgency
- pollakiuria
- dysuria
- lumbar and/or pelvic pain
- abnormal urine appearance: cloudy, malodorous, macroscopic haematuria
- absence of leucorrhoea
- specifically in people \> 70 years old:
- recent onset urinary incontinence
- sudden confusion
- bladder globe
- +14 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CNGE Conseillead
Study Sites (1)
Cabinet de groupe
Saint-Maur-des-Fossés, Saint Maur, 94100, France
Related Publications (7)
Caron F, Galperine T, Flateau C, Azria R, Bonacorsi S, Bruyere F, Cariou G, Clouqueur E, Cohen R, Doco-Lecompte T, Elefant E, Faure K, Gauzit R, Gavazzi G, Lemaitre L, Raymond J, Senneville E, Sotto A, Subtil D, Trivalle C, Merens A, Etienne M. Practice guidelines for the management of adult community-acquired urinary tract infections. Med Mal Infect. 2018 Aug;48(5):327-358. doi: 10.1016/j.medmal.2018.03.005. Epub 2018 May 16. No abstract available.
PMID: 29759852BACKGROUNDGrigoryan L, Trautner BW, Gupta K. Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA. 2014 Oct 22-29;312(16):1677-84. doi: 10.1001/jama.2014.12842.
PMID: 25335150BACKGROUNDSoudais B, Lacroix-Hugues V, Meunier F, Gillibert A, Darmon D, Schuers M. Diagnosis and management of male urinary tract infections: a need for new guidelines. Study from a French general practice electronic database. Fam Pract. 2021 Jul 28;38(4):432-440. doi: 10.1093/fampra/cmaa136.
PMID: 33340317BACKGROUNDKinouani S, de Lary de Latour H, Joseph JP, Letrilliart L. Diagnostic strategies for urinary tract infections in French general practice. Med Mal Infect. 2017 Oct;47(6):401-408. doi: 10.1016/j.medmal.2017.05.003. Epub 2017 Jun 9.
PMID: 28606664BACKGROUNDVincent YM, Frachon A, Buffeteau C, Conort G. Construction of a patient decision aid for the treatment of uncomplicated urinary tract infection in primary care. BMC Fam Pract. 2021 Jan 26;22(1):26. doi: 10.1186/s12875-021-01374-3.
PMID: 33499824BACKGROUNDPiraux A, Faure S, Naber KG, Alidjanov JF, Ramond-Roquin A. Changes in the management of urinary tract infections in women: impact of the new recommendations on antibiotic prescribing behavior in France, between 2014 and 2019. BMC Health Serv Res. 2021 Jun 28;21(1):612. doi: 10.1186/s12913-021-06653-4.
PMID: 34182991BACKGROUNDLugtenberg M, Burgers JS, Zegers-van Schaick JM, Westert GP. Guidelines on uncomplicated urinary tract infections are difficult to follow: perceived barriers and suggested interventions. BMC Fam Pract. 2010 Jun 28;11:51. doi: 10.1186/1471-2296-11-51.
PMID: 20584276BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Véronique ORCEL, Dr
Département Universitaire d'Enseignement et de Recherche de Médecine Générale de Créteil
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2023
First Posted
May 6, 2023
Study Start
December 15, 2023
Primary Completion
January 31, 2025
Study Completion
January 31, 2025
Last Updated
July 3, 2024
Record last verified: 2024-07